Explore recent and upcoming breakthroughs in the field of psychedelic science and therapy. Learn how science is changing how the world thinks about psychedelics with the Multidisciplinary Association for Psychedelic Studies (MAPS), a non-profit drug development organization now in the final stages of research to make MDMA-assisted psychotherapy an FDA-approved treatment for posttraumatic stress disorder (PTSD). Connect with leaders, researchers, and movement makers creating a new paradigm of mental health with psychedelics.

Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.